Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

ZO-1 helps hair follicle stem cells renew better by changing their structure.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Ruxolitinib can cause a delayed skin reaction on the nose.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Using ultrasound may make cisplatin more effective against cervical cancer in mice.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Rituximab can cause skin issues, but baricitinib may help improve them.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.